Research on diseases of the heart and blood vessels. Covers microvascular imaging, light exposure, cardiac imaging anxiety, and sex differences in risk.
A secondary analysis of a randomized clinical trial found that cardiovascular disease mortality was similar among individuals with hypertension receiving diuretics, calcium channel blockers, or ACE inhibitors. However, ACE inhibitors were associated with an increased risk of stroke outcomes by 11% compared to diuretics.
A new study finds that consuming more oily fish like salmon and mackerel can lower the risk of cardiovascular diseases in people with a family history. The research suggests that these fatty acids EPA/DHA play a crucial role in mitigating this risk, especially for those with close relatives who have suffered from cardiovascular disease.
The Joint Action on Cardiovascular Diseases and Diabetes (JACARDI) aims to reduce the burden of cardiovascular diseases and diabetes in EU member states through 143 pilot projects. The project will test and offer solutions throughout the patient journey, focusing on prevention, early detection, treatment, care, and self-management.
According to a new study published in Annals of Internal Medicine, most adults who qualify for statin use for primary prevention are not receiving them. The study found that despite increased overall statin use over time, only 35% of eligible adults were taking statins between 2013 and 2018. The researchers suggest that innovative effo...
A recent study published in Circulation: Genomic and Precision Medicine reveals that genetics significantly contribute to the sex differences in hypertension development. The research found that females with high genetic risk scores had a higher risk of hypertension compared to males, while low-risk females had a lower risk than males.
Significant racial and ethnic disparities in atherosclerotic cardiovascular disease treatment were found in a study of 5,218 adults. The disparities persisted despite optimal recommended therapies, underscoring the need for sustained efforts to achieve better outcomes for all patients regardless of their background.
The new guideline emphasizes the importance of disease prevention, risk factor modification, and optimized therapies to manage atrial fibrillation. It also updates guidelines for catheter ablation, anticoagulants, and heart rate management, aiming to improve patient outcomes and reduce stroke risk.
A study conducted by Eurac Research Institute found that cigarette use alters the oral microbiome, leading to an increased risk of periodontitis and cardiovascular disease. Quitting smoking results in a gradual increase in aerobic bacteria, which can lead to improved blood pressure regulation.
Research found a significant linear relationship between age of coronary heart disease onset and dementia, highlighting the detrimental influence of premature cardiovascular events on brain health. Adults diagnosed with coronary heart disease at a young age may be at increased risk of developing dementia, Alzheimer's disease, and vascu...
Adults with congenital heart disease are at increased risk of death or cardiovascular complications after hospitalization for heart failure. However, those who received recent cardiology care before hospital admission had lower rates of death and major complications.
Despite its cost-effective prevention for recurrent events, cardiac rehabilitation remains inaccessible to many due to lack of social support, particularly in poorer countries. Home-based rehabilitation and comprehensive lifelong healthy behavioral programs may help address these barriers.
A two-year study found that participants who received personalized coaching experienced a modest boost in cognitive testing, measuring a 74% improvement over the non-intervention group. Additionally, improvements were noted between the two groups in measurements of risk factors and quality of life.
Two large studies found that people with ADHD who take medication for a long time and in higher doses are at a higher risk of developing some cardiovascular diseases. The highest rate of discontinuation occurred among 18 to 19-year-olds, highlighting the need for better transition to adult psychiatry services.
The American Heart Association and Neurocritical Care Society emphasize the need for improved critical care management of patients after cardiac arrest. The consensus statement highlights gaps in knowledge, particularly in areas like neurological, cardiac, and gastrointestinal care.
A new study identified 60 alcohol-associated circulating metabolites that appear to produce counteractive effects on the risk of heart disease. The findings suggest that moderate alcohol consumption may trigger changes in metabolomic profiles, yielding both beneficial and harmful outcomes.
Researchers at UCSF and Kaiser Permanente Washington found that participants who received personalized coaching experienced a 74% improvement in cognitive testing compared to non-intervention participants. The study also showed improvements in risk factors and quality of life, with modest but significant increases in cognitive function.
Biomedical engineers at Duke University created a new 'digital twins' framework using smartwatch data to capture personalized arterial forces over 700,000 heartbeats. This approach reduces the computational load by simulating tasks in parallel, enabling real-time tracking of cardiovascular disease progression and risk assessment.
Researchers found that breathing unfiltered highway air significantly increases passengers' blood pressure during rush-hour traffic. The study's findings suggest a complex mechanism by which traffic-related air pollution interferes with blood pressure regulation.
The Global Centre for Asian Women’s Health found that a Mediterranean diet rich in fruits, nuts, whole grains, and healthy fats can reduce the risk of gestational hypertension and preterm birth. The study also linked narrowing of retinal arterioles before conception to reduced fetal growth during pregnancy.
Researchers developed an AI tool that can identify never-smokers at high risk for lung cancer based on their chest X-ray images. The study found that 28% of non-smokers were deemed high risk by the model, and these patients had a 2.1 times greater risk of developing lung cancer compared to low-risk individuals.
A study of 278,000 individuals in Sweden found that longer cumulative duration of ADHD medication use was associated with an increased risk of hypertension and arterial disease. Clinicians should regularly monitor cardiovascular signs and symptoms during long-term treatment.
A simulation study suggests that a soft drink tax in Germany would reduce sugar consumption and illness rates, including type 2 diabetes, resulting in significant financial savings. The estimated economic benefits of introducing such a tax range from 9.5 billion to 16 billion euros over the next two decades.
Thirty-two institutions earned the SET-10 distinction, with top ten recognized globally for their dedication to advancing scientific knowledge in interventional cardiovascular medicine. The rankings span six categories and acknowledge excellence within and outside the United States.
A new study reveals that younger people are more vulnerable to the effects of high blood cholesterol and hypertension, atherosclerosis can be reversed if risk factors are controlled early enough. The study suggests aggressive control of cardiovascular risk factors at younger ages.
Researchers from Karolinska Institutet found a weaker association between adolescent physical fitness and later cardiovascular disease risk. High BMI remained a strong individual risk factor for cardiovascular disease in late adolescence.
The American Heart Association's National Hispanic Latino Cardiovascular Collaborative aims to bridge the gap in healthcare disparities affecting underrepresented groups. By empowering Hispanic Latino leaders, the program seeks to eliminate health inequities and improve overall well-being.
A national study found that exposure to environmental hazards in neighborhoods is associated with poor cardiovascular health, particularly among socioeconomically disadvantaged communities. The study used the Environmental Justice Index to assess cumulative environmental burden and its impact on cardiovascular risk factors and diseases.
A recent study in Nature Communications has identified a gene cluster in wheat that produces triticein, an isoflavone compound with potential health benefits. This discovery offers opportunities for metabolic engineering efforts to improve wheat's nutritional quality and resistance to disease.
Researchers at Uppsala University have developed an instrument to measure 21 biomarkers for cardiovascular disease, improving prediction and treatment. The CVD-21 panel reflects functional disturbances influencing cardiovascular development and treatment outcomes.
A study co-authored by past presidents of The Obesity Society shows that Wegovy can reduce existing heart disease in patients with obesity. The medication, semaglutide, was found to be life-saving and can benefit all sub-groups studied.
A study of US neighborhoods found a strong association between environmental burden and higher rates of cardiovascular risk factors and diseases. Socially vulnerable neighborhoods showed the strongest associations, highlighting the need for initiatives to address poor environmental conditions and improve cardiovascular health.
Scientists at the University of Leicester have made a groundbreaking discovery about how cholesterol in our diet is absorbed into our cells. The research, published in Science, highlights the role of two proteins called Aster B and Aster C in transporting cholesterol from the intestine to the bloodstream.
A 20% reduction in major adverse cardiovascular events has been observed for patients with obesity but no history of diabetes taking semaglutide. This study marks a significant milestone, demonstrating the cardiovascular benefits of semaglutide beyond its weight loss effects.
A three-year intensive treatment strategy to lower systolic blood pressure below 120mmHg significantly reduced cardiovascular events, including heart attack, stroke, and death, compared to standard treatment. The study found that participants in the intensive group experienced fewer major vascular events and deaths over a two-year period.
A new study suggests that a PCSK9 inhibitor given every 1-3 months may effectively lower bad cholesterol levels in people with non-genetic hypercholesterolemia. The medication, recaticimab, showed similar effectiveness and safety as other PCSK9 inhibitors when administered less frequently.
Patients with heart failure treated with dapagliflozin experienced frequent initial estimated glomerular filtration rate declines, but without increased cardiovascular or kidney event risks. The study suggests that sodium-glucose cotransporter-2 inhibitors can be safely continued in patients experiencing eGFR decline.
Researchers found that abelacimab, a Factor XI inhibitor, reduced bleeding compared to rivaroxaban in patients with atrial fibrillation. The study showed significant reduction in hospitalization due to bleeding and almost eliminated gastrointestinal bleeding.
The ORBITA-2 trial found that stenting improves symptoms compared to a placebo procedure, providing evidence-based treatment for stable chest pain. The study suggests updating guidelines for stable coronary artery disease and offers patients and medical teams two treatment strategies with similar benefits.
Researchers found that people with overweight or obesity who took semaglutide for over 3 years had a 20% lower risk of heart attack, stroke, or death from cardiovascular disease. The study showed significant weight loss and improved cardiovascular outcomes in adults without diabetes.
A recent clinical trial found that semaglutide significantly reduced cardiovascular events in adults with overweight or obesity who do not have diabetes. The medication was shown to lower the risk of death from cardiovascular causes, nonfatal heart attacks, and strokes by 20% compared to placebo.
A new risk calculator estimates a person's risk for cardiovascular disease (CVD) over the next 30 years by combining measures of cardiovascular, kidney, and metabolic health. The PREVENT risk calculator uniquely quantifies risks for CVD for each biological sex, without including race as a factor.
A Pitt University study found that individuals with higher education levels are less likely to experience cardiovascular disease events later in life. On average, those with less than a high school education were 1.4-1.7 times more likely to have a heart attack or stroke compared to college graduates.
A new study finds that people with antibodies to common foods like dairy and peanuts are at a higher risk of cardiovascular-related death. The research suggests that these subtle immune responses may lead to inflammation and contribute to heart disease over time.
A new study found that workplaces implementing flexible work arrangements can reduce employees' cardiometabolic risk, equivalent to a reduction of 5-10 years in age-related changes. The intervention had no negative impact on productivity and was particularly beneficial for low- and middle-wage workers.
Researchers at the University of São Paulo have tested a synthetic molecule called AD-9308, which has shown potential in treating heart failure by activating the enzyme aldehyde dehydrogenase 2. The study found that the molecule improved mitochondrial filtration, eliminating cellular pollutants and boosting heart function by up to 40%.
A recent study in JAMA Cardiology analyzed data from 15,000 patients and found that enteric coating on aspirin does not change its effectiveness or safety for secondary prevention of cardiovascular events. The study suggests that patients can choose the aspirin formulation that suits them best.
Two new studies reveal that depression, anxiety and chronic stress increase the risk for heart and brain health complications. Researchers found that these mental health conditions can accelerate the development of cardiovascular disease risk factors.
Researchers have developed AI tools that can effectively detect heart valve disease and predict cardiovascular risk using digital stethoscopes. A study found that AI-powered digital stethoscopes predicted nearly 90% of valve disease diagnoses, offering a promising tool for transforming CVD care.
Research highlights significantly higher heart attack death rates among American Indian and Alaska Native adults, particularly at younger ages. The study suggests that factors like limited healthcare access, socioeconomic conditions, and restricted health insurance coverage may contribute to these disparities.
Yabing Chen has received two NIH grants totaling over $5 million to investigate vascular diseases and their link to dementia. Her research focuses on Runx2, a master transcription factor involved in both bone formation and calcification of arteries.
Two reproductive health conditions, polycystic ovary syndrome and dysmenorrhea, are linked to increased cardiovascular disease risk in women. Studies suggest that girls with polycystic ovary syndrome have a 30% higher risk of high blood pressure, while women with dysmenorrhea are twice as likely to experience ischemic heart disease.
A new study finds that higher cardiovascular health is associated with decelerated biological aging, as measured by phenotypic age. Greater adherence to all Life's Essential 8 metrics can slow down the body's aging process and have numerous benefits.
A recent study has found that transgender adults living in rural areas of the US are more likely to have cardiovascular disease risk factors such as tobacco use, obesity, and high blood pressure. The research highlights the need for targeted interventions to reduce health disparities among this population.
The American Heart Association has selected five finalists in its 6th annual Health Tech Competition to present their innovative technologies. The competition aims to drive technology innovation and transform the landscape of heart and brain health.
A new pathway to prevent cardiovascular disease has been discovered through a University of Minnesota-led study, highlighting the potential of TREM2 as an immunotherapeutic target. The research found that deleting the TREM2 gene in macrophages inhibited atherosclerosis progression.
A recent study analyzing global and national trends of atherosclerosis found an increasing trend in incidence from 1990 to 2019, driven by adults aged 20–54. The burden of the disease is particularly concerning in low- and middle-income countries, where it is rising significantly due to lifestyle factors and aging populations.
Greater PTSD symptoms were associated with higher carotid atherosclerosis and brain small vessel disease among midlife women. Women carrying the APOEɛ4 gene showed poorer cognitive performance in response to PTSD.
A new study from Tulane University found that frequent salt consumption is associated with a higher risk of developing Type 2 diabetes. The study surveyed over 400,000 adults and found participants who regularly added salt had a 13% to 39% increased risk of developing the disease compared to those who never or rarely used salt.
Dr. Olugbenga Ogedegbe has been recognized for his pioneering research on health disparities, chronic diseases, and cardiovascular risk reduction, particularly among Black adults in the US. His work aims to reduce hypertension control and racial inequities in cardiovascular disease outcomes.
A new wearable ECG device weighs only 10 grams and has just three 'dry' electrodes that are almost invisibly thin, capturing the heart's electrical activity with comparable precision to market devices. The device can be used for continuous monitoring and is ideal for patients in remote healthcare and ambulatory care settings.